semaglutide thyroid cancer risk (Ozempic) carries FDA warnings for C-cell tumors based on rodent studies, with emerging human data showing higher thyroid in early users. Over 2,900 lawsuits allege inadequate warnings for Just a word of caution

If you answered no to most or all, you likely do not need routine testing

We watch for changes in mood, eating behaviors, substance use, anything concerning

High Out-of-Pocket Costs: Even if your GLP-1 medication is covered, you may still face high out-of-pocket costs, especially if the medication is in a higher tier on your plans formulary

Starting with a low dose and gradually increasing it, as prescribed, helps minimise gastrointestinal side effects

While direct comparisons are imperfectdifferences in study duration, patient populations, and dosing schedules complicate head-to-head analysesthe pattern is clear: by engaging GLP-1, GIP, and glucagon pathways simultaneously, retatrutide appears to deepen and extend weight loss beyond what single- or dual-agonist drugs achieve